Nov. 13, 2025 Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it. Tests showed that removing this RNA slows cancer growth. The approach could lead to new treatments that attack cancer at its most fundamental ...
RELATED TOPICS
Nov. 13, 2025 Scientists have discovered strange microscopic structures in the blood of people with Long COVID—clusters of tiny microclots tangled together with sticky immune webs known as neutrophil extracellular traps, or NETs. These combined structures show up far more often in Long COVID patients, where they appear larger, denser, and more stubborn than in healthy ...
RELATED TOPICS
Nov. 12, 2025 Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular disease. Trials involving nearly 23,000 patients show meaningful reductions in risk with low doses. Side effects were mostly mild and short-lived. Researchers say this overlooked drug could become an accessible prevention tool pending further ...
RELATED TOPICS
Nov. 12, 2025 Scientists have uncovered a new environmental culprit behind liver disease: tetrachloroethylene (PCE), a chemical used in dry cleaning and household products. The study found that people with PCE exposure were three times more likely to develop severe liver scarring, even when traditional risk factors like alcohol or obesity were absent. The chemical is widespread in air, water, and consumer ...
RELATED TOPICS
Nov. 9, 2025 Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, Denmark, and Germany are developing a genetic test to predict which medications will actually work. Using polygenic risk scores, they can analyze DNA variations linked to mental health and drug ...
RELATED TOPICS
Nov. 8, 2025 Sertraline (Zoloft) may relieve emotional symptoms of depression and anxiety within two weeks, while physical side effects stabilize later. The research highlights how antidepressants can act on specific symptom networks rather than uniformly across all aspects of ...
RELATED TOPICS
Nov. 6, 2025 Weill Cornell researchers uncovered how free radicals from astrocyte mitochondria can fuel dementia. Using new compounds that target these radicals at their source, they slowed brain inflammation and neuronal damage in mice. The findings reveal a potential breakthrough for treating diseases like Alzheimer’s and frontotemporal dementia by focusing on the precise mechanisms driving ...
RELATED TOPICS
Nov. 5, 2025 Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older rats. Another experiment revived a silenced memory gene, IGF2, through targeted DNA methylation editing. These findings highlight that aging brains can regain function through precise molecular ...
RELATED TOPICS
Nov. 12, 2025 New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, semaglutide (Ozempic) and tirzepatide (Mounjaro), not only promote weight loss but also significantly reduce the risk of heart attacks and strokes in patients with type 2 diabetes. Using real-world insurance data, the study found up to an 18% reduction in major cardiovascular ...
RELATED TOPICS
Nov. 12, 2025 Scientists in Seoul have uncovered 15 gut bacterial species linked to coronary artery disease, showing that microbes can influence heart health far beyond digestion. Their findings reveal how shifts in gut microbial function — including inflammation, loss of protective species, and overactive metabolic pathways — may drive disease progression. Intriguingly, even “good” bacteria like ...
RELATED TOPICS
Nov. 12, 2025 GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of non-users. Researchers suspect the drugs’ anti-inflammatory and metabolic effects contribute to improved outcomes. They’re now calling for clinical trials to test whether these findings reflect a ...
RELATED TOPICS
Nov. 11, 2025 TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional short-term treatments. The therapy may replace bladder removal surgery for many and has earned FDA Priority Review due to its impressive ...
RELATED TOPICS